Veeva Introduces AI Agent for Clinical Study Configuration

Sep 24, 2026
Veeva Study Builder Agent configures clinical studies from protocols and automates testing. Early access is planned for December 2026.

Veeva Systems announced in a press release Study Builder Agent, an AI tool that configures Veeva EDC and Veeva DQS directly from a study protocol. The tool reuses an organization's existing standards and supports the CDISC Unified Study Definitions Model.

Study Builder Agent configures EDC forms, visits, validation rules and CQL based DQS listings. It also automates testing and generates test data. Veeva says the process minimizes deviations from standards and produces audit ready results.

Veeva plans to make the agent available to early users in December 2026. It will be included with Veeva EDC at no additional license cost and delivered as a Claude Cowork plugin through a GitHub repository managed by Veeva.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.